← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Bajaj Finserv Equity Savings Fund

Regular Plan · IDCW · Equity Savings · Scheme code 153771

Fund houseBajaj Finserv Mutual Fund
CategoryEquity Savings
Plan & optionRegular · IDCW
History1.0 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 0.661.362.07 4.24 4.24
Nifty 100
benchmark
0.253.49-1.52 1.8410.529.38 12.79
Equity Savings
category median
5.048.567.72 8.06

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 2.3% -1.00 -1.52 0.14 -1.82% -1.3% 81.45
Nifty 100
benchmark
17.1%0.23 0.32 -37.0%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 12 months this scheme and its benchmark share.

Growth of ₹100 since launch

1001011031052026InvestVerdict

Drawdown from peak (%)

0%0%-1%-1%2026
InvestVerdict

Bajaj Finserv Equity Savings Fund

Regular Plan · IDCW

Allocation

By asset

Equity70.59%
Mutual Fund Units21.78%
Cash & Equivalents6.75%
REITs / InvITs0.88%

By market cap

Concentration

Number of stocks50
Top 5 stocks40.06%
Top 10 stocks52.93%
Top 20 stocks71.12%
Largest holding21.78%
Largest sectorUnclassified 21.78%
Effective stocks15.3
Cash6.75%
InvestVerdict

Bajaj Finserv Equity Savings Fund

Regular Plan · IDCW · holdings

Sector split

Unclassified — 21.8%Banks — 16.1%Cash & Equivalents — 6.8%Pharmaceuticals & Biotechnology — 6.5%Diversified FMCG — 5.9%Finance — 5.7%Aerospace & Defense — 3.8%Other — 33.5%Unclassified21.8%Banks16.1%Cash & Equivalents6.8%Pharmaceuticals & Biotech…6.5%Diversified FMCG5.9%Finance5.7%Aerospace & Defense3.8%Other33.5%
Unclassified21.78%
Banks16.12%
Cash & Equivalents6.75%
Pharmaceuticals & Biotechnology6.46%
Diversified FMCG5.89%
Finance5.70%
Aerospace & Defense3.83%
Chemicals & Petrochemicals2.68%
Industrial Products2.62%
Construction2.58%

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Aug 2026.